Collectively, the observed effects on B cells and DCs confirm the functionality of the CD40L extracelluar domain and, moreover, provide support for our proposed hypothetical mode of action of CD40L:CD28 CSP-expressing T cells where tumor-resident APCs can receive the benefit of stimulation through the CSP to rescue their activity in the TME. Here, CD28 is linked to neoplasm.